Argá Medtech today announced it closed a €54 million oversubscribed Series B funding round to support its pulsed field ablation technology. The Lausanne, Switzerland-based company develops the Coherent Sine-Burst Electroporation pulsed field ablation system for treating cardiac arrhythmias, including atrial fibrillation. Argá’s latest financing will allow the company to advance the development of its CSE […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
J&J’s Biosense Webster begins trial for Laminar left atrial appendage elimination device
Johnson & Johnson’s Biosense Webster today announced the start of patient cases with the investigational Laminar LAAX system. In November 2023, Johnson & Johnson MedTech completed a $400 million acquisition of Laminar, With that buy, the company brought in Laminar’s left atrial appendage elimination (LAAX) technology. Unlike other LAA technologies, which exclude or occlude the […]
Mitral valve repair company NeoChord has a new CEO
NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair. Minneapolis-based NeoChord develops technology for the delivery of artificial chords to treat mitral valve regurgitation. In the role, Berg oversees the clinical and commercial programs for the transeptal and transapical repair of damaged mitral valve chords. […]
iRhythm stock dips on mixed Q4 as guidance ‘may disappoint’ investors
iRhythm Technologies shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast. Shares of IRTC fell 5.5% at $108.75 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The San Francisco-based heart monitoring technology […]
LivaNova stock rises on strong Q4, massive bottom-line uptick
LivaNova shares got a boost today on fourth-quarter results that came in well ahead of the consensus forecast. Shares of LIVN ticked up nearly 9% at $57.28 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.4%. The London-based medtech company […]
FDA clears wearable EP monitoring patch from X-trodes
X-trodes announced today that it received FDA 510(k) clearance for a new wireless wearable technology for electrophysiological (EP) monitoring. The Herzliya, Israel-based company calls its solution “Smart Skin,” although it plans to market it in the U.S. as the X-trodes System M. Smart Skin features a customizable, dry-printed, multi-modal electrode patches. It monitors a wide […]
AngioDynamics sells PICC and Midline portfolios for $45M, discontinues sales of radiofrequency ablation devices
AngioDynamics recently announced the sale of its PICC and Midline product portfolios to Spectrum Vascular for up to $45 million in cash. The company PICC, Midline and tip location products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023. The transaction consists of $34.5 million paid at closing, an earnout related to […]
BioSig reduces workforce again, will ‘substantially’ cut operations
BioSig Technologies (Nasdaq:BSGM) announced today that it terminated “a significant number of its employees.” Shares of BSGM were up 3.1% to 64¢ apiece in mid-morning trading today following the announcement. With this latest workforce reduction, the company says it expects to “substantially reduce business operations.” Today’s announcement marks the company’s second significant headcount cut in […]
BiVacor raises $13M to support artificial heart trial
BiVacor announced today that it brought in $13 million from the Australian government to support its Total Artificial Heart program. Australia’s Medical Research Future Fund (MRFF) provided a grant through its Artificial Heart Frontiers Program (AHFP). It aims to support the company’s TAH program and future product enhancements. BiVacor received FDA investigational device exemption to […]
AtriCure grows sales by 21% in Q4
AtriCure shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast. Shares of ATRC fell 2.8% at $33.25 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 0.7%. The Mason, Ohio-based company posted losses of $9.8 million. That […]
Boston Scientific completes first commercial Farapulse cases in U.S.
Boston Scientific has completed the first post-FDA approval cases in the U.S. with its Farapulse pulsed field ablation system. In a LinkedIn post, Nick Spadea-Anello, president, Electrophysiology, Boston Scientific, announced the first commercial use for the AFib treatment. Marlborough, Massachusetts-based Boston Scientific won the approval for Farapulse last month. In doing so, it became second […]